Cochlear Limited
14 Mars Road
PO Box 629
Lane Cove
NSW 2066
Tel: 61-2-9428-6555
Fax: 61-2-9428-6353
Website: http://www.cochlear.com/
46 articles about Cochlear Limited
-
The company will continue to analyze data regarding the secondary endpoints.
-
Sensorion and Cochlear to Begin First Clinical Trial of SENS-401 for Hearing Preservation in Combination With Cochlear Implantation
9/8/2021
Sensorion a pioneering clinical-stage biotechnology, which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, and Cochlear Limited, the global leader in implantable hearing solutions, announce the initiation of a pilot study of the first-in-class small molecule drug SENS-401 in patients scheduled for cochlear implantation.
-
Cochlear welcomes landmark WHO report calling on governments and societies to prioritize hearing health
3/3/2021
Cochlear has joined people with hearing loss, hearing care experts and advocates in welcoming the World Health Organization's landmark World Report on Hearing, which calls upon governments and societies to prioritize hearing health.
-
Cochlear obtains FDA approval of Kanso 2 Sound Processor, first off-the-ear cochlear implant sound processor with direct smartphone connectivity
7/6/2020
Approval also includes extending the Nucleus 7 Sound Processor to the first U.S. cochlear implant recipients, Custom Sound Pro fitting software to enhance support for hearing professionals
-
As surgeries resume, pediatric cochlear implantation can now be done as young as 9 months
5/19/2020
Cochlear received FDA approval to lower the age of implantation at the beginning of COVID-19 crisis; earlier access to cochlear implantation for children provides opportunity for better hearing, speech and language outcomes in children born deaf
-
FDA expedites approval of Cochlear's Remote Check solution for cochlear implants
4/7/2020
Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) approval on April 2 for its Remote Check solution. This approval is the first step in
-
Cochlear reveals winners of annual flagship scholarship programs
1/27/2020
Eight Cochlear recipients recognized for their achievements in academia, leadership and humanity with $64,000 in funding for further academic endeavors
-
FDA clears Cochlear's innovative new Osia® 2 hearing implant system
12/11/2019
Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announces today the U.S. Food and Drug Administration (FDA) clearance of the new Cochlear™ Osia® 2 System.
-
Top 5 Vendors in the Global Middle Ear Implants Market 2019-2023 | Technavio
7/11/2019
The middle ear implants sector has undergone significant technological advancements which have led to an increase in adoption among end-users.
-
FDA approves new cochlear implant with easier access to MRI and expanded connectivity ready for Google's direct streaming to Android smartphones
6/17/2019
Cochlear delivers Nucleus Profile Plus Implant, first cochlear implant manufacturer to enable Android direct connectivity with the Nucleus 7 Sound Processor
-
Survey reveals hearing loss can significantly affect relationships and families in the U.S.
5/1/2019
State of Hearing Report highlights the physical, emotional and societal challenges of hearing loss
-
Cochlear and GN Hearing Strengthen Technology and Commercial Alliance to Develop Best-in-Class Integrated Hearing Solutions
11/8/2018
Cochlear Limited and GN today signed a new agreement to significantly expand their Smart Hearing Alliance collaboration.
-
'See Sound Differently,' take the #MillionEar Challenge to protect your hearing this Better Hearing & Speech Month
4/26/2018
This Better Hearing and Speech Month (BHSM), Cochlear Limited (ASX: COH) launches the "See Sound Differently" video campaign for its annual #MillionEar Challenge initiative to bring hearing health awareness to more than 1 million people during the month of May.
-
Cochlear Americas Announces the Release of the Baha SoundArc
1/22/2018
Cochlear Limited announces today the commercial availability of the new Cochlear Baha SoundArc in the United States and Canada.
-
Sensorion and Cochlear Announce Collaboration to Study Combination Therapies for Cochlear Implant...
12/19/2017
The collaboration will evaluate therapeutic approaches using SENS-401 in combination with cochlear implants, with preclinical studies initiating in 2018, and potential clinical trials to begin as soon as 2019. -
This approval is the first in the cochlear implant industry and one of many steps Cochlear is taking to enable remote care for Nucleus Cochlear Implant recipients and clinicians.
-
Cochlear Limited CEO to Retire, New CEO Named
7/31/2017
-
Cochlear Limited Introduces The World's First Made For iPhone Cochlear Implant Sound Processor
7/26/2017
-
Australia's Cochlear Limited Plans $39 Million Manufacturing Facility In Chengdu
7/14/2017
-
Aussie Firm Cuts "Off-Air" Time For Cochlear Implant Recipients, Cochlear Limited Reveals
10/19/2016